Обзор материалов 89 конгресса Европейского общества по изучению атеросклероза (EAS), проходившего 30 мая-02 июня 2021 г. в онлайн-формате

G. G. Arabidze

doi:10.34687/2219-8202.JAD.2021.04.0007

Review on the materials of the 89th congress of the European Society for atherosclerosis (EAS) held on May 30-June 2, 2021 in on-line format

Authors

G. G. Arabidze Moscow State University of Medicine and Dentistry named after A. I. Evdokimov Ministry of Pablic Health of the Russian Federation, Moscow, Russia

DOI:

https://doi.org/10.34687/2219-8202.JAD.2021.04.0007

Keywords:

atherosclerosis, lipid disorders, lipid-lowering therapy, low-density lipid cholesterol.

Abstract

Nowadays coronary artery disease (CAD) is the most common cause of death in developed countries, and Reports from the materials of the 89th Congress of the EUROPEAN SOCIETY FOR ATHEROSCLEROSIS (EAS) covering various areas of research in modern clinical lipidology from various European countries. Studies devoted to both the development of new methods of the treatment atherosclerotic diseases, and the diagonostics of lipid metabolism disorders and their complications using the most modern instrumental and laboratory techniques are discussed.

Downloads

Download data is not yet available.

Downloads

PDF (Русский)

Published

2022-01-14

How to Cite

Arabidze G. G. Review on the materials of the 89th congress of the European Society for atherosclerosis (EAS) held on May 30-June 2, 2021 in on-line format // The Journal of Atherosclerosis and Dyslipidemias. 2022. VOL. № 4 (45). PP. 59–62.